Recombinant Rat Chondroitin Sulfate Proteoglycan 4 (CSPG4)
Recombinant Rat Chondroitin Sulfate Proteoglycan 4 (CSPG4) is a purified Prokaryotic Protein. Purity: >95% by SDS-PAGE. Host: E. coli. Endotoxin Level: <1.0EU per 1ug, by the LAL method. Species: Rat (Rattus norvegicus) . Target Name: Chondroitin Sulfate Proteoglycan 4 (CSPG4) . Target Synonyms: CSPG4; MSK16; HMW-MAA; MCSP; MCSPG; MEL-CSPG; NG2; Chondroitin Sulfate Proteoglycan 4; Melanoma chondroitin sulfate proteoglycan. Accession Number: Q00657. Gene ID: 81651. Expression Region: Gly1919~Lys2258. Tag Info: N-terminal His and GST Tag. Theoretical MW: 66kDa. Buffer: PBS, pH7.4, containing 0.01% SKL, 5% Trehalose. Storage: -20°C. Avoid repeated freeze/thaw cycles. Restrictions: For Research Use Only. Not for use in diagnostic procedures.
Product Specifications
CAS Number
9000-83-3
Short Description
Recombinant Rat Chondroitin Sulfate Proteoglycan 4 (CSPG4) is a purified Prokaryotic Protein.
Gene ID
81651
Accession Number
Q00657
Expression Region
Gly1919~Lys2258
Expression System
Prokaryotic Expression
Host
E. coli
Target
Chondroitin Sulfate Proteoglycan 4 (CSPG4)
Conjugation
Unconjugated
Tag
N-Terminal His and GST Tag
Applications
Positive Control, Immunogen, SDS-PAGE, WB
Field of Research
Tumor Immunity
Endotoxin
<1.0EU/ug, by the LAL method
Purity
>95% by SDS-PAGE
Activity
Not Tested
Format
Freeze-dried powder
Buffer
PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
Reconstitution
Refer to the datasheet/CoA included in the product pouch.
Molecular Weight
66kDa
Shipping Conditions
Ice packs
Storage Conditions
-20°C. Avoid repeated freeze/thaw cycles.
Target Alternative Name
CSPG4; MSK16; HMW-MAA; MCSP; MCSPG; MEL-CSPG; NG2; Chondroitin Sulfate Proteoglycan 4; Melanoma chondroitin sulfate proteoglycan
Species
Rat (Rattus norvegicus)
Protein Name
Prokaryotic Protein
Available Sizes
Explore Other Products
Browse additional items from our catalog
Rabbit Anti-Human TUBB3 Monoclonal Antibody, Clone S19-7B4
2310022A10Rik sgRNA CRISPR Lentivector (Mouse) (Target 1)
LMNL2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)